サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1562251

北米のトランスフェクション試薬・機器：2030年までの市場予測 - 地域分析 - 製品、手法、用途、エンドユーザー別

North America Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product, Method, Application, and End User

出版日
ページ情報
英文 108 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
北米のトランスフェクション試薬・機器：2030年までの市場予測 - 地域分析 - 製品、手法、用途、エンドユーザー別
出版日: 2024年07月04日
発行: The Insight Partners
ページ情報: 英文 108 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米のトランスフェクション試薬・機器市場は、2022年に5億4,057万米ドルと評価され、2030年には9億9,553万米ドルに達すると予測され、2022年から2030年までのCAGRは7.9%と推定されます。

北米トランスフェクション試薬・機器市場を支える企業の戦略的取り組み

北米のトランスフェクション試薬・機器市場で事業を展開する企業は、共同研究、事業拡大、契約、提携、新製品発売などの戦略的開拓に注力しており、売上の向上、地理的範囲の拡大、既存顧客よりも多くの顧客に対応するための能力強化に貢献しています。また、こうした発展は、市場に新しい動向をもたらす一因にもなっています。北米のトランスフェクション試薬・機器市場における注目すべき動向のいくつかを以下に示します。

2023年4月、サーモフィッシャーサイエンティフィック社は、Invitrogen Neon NxTエレクトロポレーションシステムを発売しました。このシステムは、最も困難なタイプの細胞でもトランスフェクションを容易にし、高効率、細胞回収率、再現性を可能にします。Neon NxT電極は、最小の表面積を提供し、より均一な電場を作り出すために最適に配置され、トランスフェクションの間、適切な生理学的条件を維持し、それによって、より多くの細胞で所望の修飾が行われることを可能にし、プロセス中に失われる細胞数を減少させる。新システムはまた、改良されたフィードバックループと人間工学に基づいた使いやすさの向上も特徴としています。2021年8月、ミルスバイオ社は遺伝子治療開発用ウイルスベクターの製造をサポートするトランスフェクション試薬とエンハンサーを提供するTransIT VirusGEN GMP製品ラインを発売しました。TransIT VirusGEN GMPトランスフェクション試薬は、組換えAAVおよびLVベクターの製造をより効率的にするために、浮遊および接着HEK 293細胞への移行ワクチンDNAの送達を強化するために開発されました。2020年7月、Polyplus-transfection SAは、細胞および遺伝子治療用のレンチウイルスおよびアデノ随伴ウイルス（AAV）産生の前臨床、臨床および商業プロセスの開発をサポートするために設計されたトランスフェクション試薬のPEIpro製品ポートフォリオについて、初のGMP準拠残留試験を開始しました。さらに、ポリプラス・トランスフェクション社は、後期および商業化段階の細胞・遺伝子治療用のPEIpro-GMP製品のデュアルソーシングも開始しました。このように、トランスフェクション試薬やシステムのような製品のイントロダクション、様々な健康問題をターゲットとした革新的な製品の開発による新製品や改良品の創出、市場競争力を維持するための新規事業の立ち上げなど、コラボレーションやパートナーシップを通じて、トランスフェクション試薬や装置の新たなプラットフォームの開発を加速させることができます。

北米のトランスフェクション試薬・機器市場概要

細胞・遺伝子治療（CGT）は、治療ニーズが未解決の重篤な希少疾病に苦しむ患者を治療するために処方されます。CGTの製造は非常に複雑なプロセスであり、インフラや専門知識の不足が大きな制約要因となっています。中間体や最終製品に関連する物流関連の課題も、企業のCGT製造能力を制限しています。CGTの製造プロセスには、「アフェレーシス」による自己細胞の抽出、専門研究所への派遣、患者への投与のためのクリニックへの送り返しが含まれ、これらすべてが厳格な品質管理のもとに行われなければならないです。米国食品医薬品局（FDA）がこれまでに承認したCGT医薬品はわずか7種類に過ぎず、新製品のパイプラインは実験的な治療法で～1,200種類に達しています。その半数は第2相臨床試験中です。このような見通しから、Chemical &Engineering News Report 2023に記載されているように、細胞治療と遺伝子治療の年間売上高はそれぞれ15％と～30％成長すると推定されています。

多くのメーカーは、CGT製品の生産と商業化に関連する障壁を克服するために、Labcorp、Lonza、Catalentなどの開発製造受託機関（CDMO）にアプローチしています。ロンザ社は、細胞・遺伝子治療薬の製造能力を強化するために約920万米ドルを投資しました。CDMOによるこのような取り組みは、米国におけるトランスフェクション試薬・機器市場の成長に寄与しています。

さらに、2022年2月、イノベーション・科学・産業相のフランソワ・フィリップ・シャンパーニュ氏は、研究チームが適切な研究室とインフラを確保し、世界レベルの研究を行うための技術部門へのアクセスを確保するため、カナダ・イノベーション財団（CFI）を通じてカナダ政府に4,500万米ドルの資金を提供すると発表しました。カナダ保健研究所（CIHR）は、ケベック創薬コンソーシアム（CQDM）と提携し、創薬と医薬品開発を加速させるための個別化医療に関する新たな共同助成プログラムを実施すると発表しました。

北米のトランスフェクション試薬・機器市場の収益と2030年までの予測（金額）

北米のトランスフェクション試薬・機器市場のセグメンテーション

北米のトランスフェクション試薬・機器市場は、製品、手法、用途、エンドユーザー、国によって区分されます。

製品別では、北米のトランスフェクション試薬・機器市場は試薬と機器に二分されます。2022年には試薬セグメントが大きなシェアを占めています。

手法別では、北米のトランスフェクション試薬・機器市場は、ウイルス法、非ウイルス法、ハイブリッド法に区分されます。2022年には非ウイルス法が最大のシェアを占めています。ウイルス法は、レトロウイルス、アデノウイルス、アデノ関連ウイルス、ヘルペスウイルスに分類されます。非ウイルス性セグメントは、物理的/機械的方法と化学的方法に二分されます。さらに、物理的／機械的方法は、エレクトロポレーション法、マイクロインジェクション法、バイオリスティック法、レーザー法、マグネトフェクション法、ソノポレーション法に細分化されます。また、化学的手法のセグメントは、リポソームベース／高脂質と非リポソーム／高脂質ベースにサブ分類されます。

用途別では、北米のトランスフェクション試薬・機器市場は生物医学研究、タンパク質生産、治療デリバリーに区分されます。バイオメディカル研究セグメントが2022年に最大のシェアを占めました。

エンドユーザー別では、北米のトランスフェクション試薬・機器市場は学術・研究機関と製薬・バイオテクノロジー企業に二分されます。2022年には、学術・研究機関セグメントがより大きなシェアを占めています。

国別に見ると、北米のトランスフェクション試薬・機器市場は米国、カナダ、メキシコに分類されます。2022年の北米トランスフェクション試薬・機器市場は米国が支配的でした。

Thermo Fisher Scientific Inc、Promega Corp、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Mirus Bio LLC、QIAGEN NV、Merck KGaA、Lonza Group AG、MaxCyte Inc、Polyplus-Transfection SAは、北米トランスフェクション試薬・機器市場で事業を展開する主要企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米トランスフェクション試薬・機器市場- 主要市場力学

  • 北米のトランスフェクション試薬・機器市場：主要市場力学
  • 市場促進要因
    • 細胞治療と遺伝子治療の人気の高まり
    • がんの経済的負担の増大
  • 市場抑制要因
    • 機器および消耗品の高コスト
  • 市場機会
    • 小規模プロセスから大規模プロセスへの拡大
  • 今後の動向
    • 企業の戦略的取り組み
  • 促進要因と抑制要因の影響

第5章 トランスフェクション試薬・機器市場：北米市場分析

  • 北米のトランスフェクション試薬・機器市場の収益、2022年～2030年
  • 北米のトランスフェクション試薬・機器市場予測分析

第6章 北米のトランスフェクション試薬・機器市場分析：製品別

  • 試薬
  • 装置

第7章 北米のトランスフェクション試薬・機器市場分析：モダリティ別

  • ウイルス
  • 非ウイルス
  • ハイブリッド

第8章 北米のトランスフェクション試薬・機器市場分析：用途別

  • 生物医学研究
  • タンパク質生産
  • 治療デリバリー

第9章 北米のトランスフェクション試薬・機器市場分析：エンドユーザー別

  • 学術・研究機関
  • 製薬・バイオテクノロジー企業

第10章 北米のトランスフェクション試薬・機器市場：国別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ

第11章 トランスフェクション試薬・機器市場：業界情勢

  • トランスフェクション試薬・機器市場における成長戦略、2020～2023年
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc
  • Polyplus-Transfection SA

第13章 付録

図表

List Of Tables

  • Table 1. North America Transfection Reagents and Equipment Market Segmentation
  • Table 2. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 4. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
  • Table 5. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
  • Table 6. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
  • Table 7. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
  • Table 8. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
  • Table 9. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 10. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
  • Table 11. North America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 12. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 13. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 14. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 15. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 16. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 17. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 18. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 19. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 20. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 21. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 22. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 23. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 24. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 25. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 26. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 27. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 28. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 29. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 30. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 31. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 32. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 33. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 34. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 35. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 36. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
  • Table 37. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market

List Of Figures

  • Figure 1. North America Transfection Reagents and Equipment Market Segmentation, by Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. North America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
  • Figure 4. North America Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
  • Figure 5. Reagents: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 6. Equipment: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. North America Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
  • Figure 8. Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Retrovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Adenovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Adeno-Associated Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Herpes Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Non-Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Physical/Mechanical: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Electroporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Microinjection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Biolistic Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Laser Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Magnetofection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Sonoporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Chemical Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Non-Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Hybrid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
  • Figure 26. Biomedical Research: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Protein Production: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Therapeutic Delivery: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. North America Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
  • Figure 30. Academic and Research Institutes: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pharmaceutical and Biotechnological Companies: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. North America: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
  • Figure 33. North America: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 34. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
目次
Product Code: BMIRE00030528

The North America transfection reagents and equipment market was valued at US$ 540.57 million in 2022 and is expected to reach US$ 995.53 million by 2030; it is estimated to register at a CAGR of 7.9% from 2022 to 2030.

Strategic Initiatives by Companies Fuel North America Transfection Reagents and Equipment Market

Companies operating in the North America transfection reagents and equipment market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic scope, and enhance their capacities to cater to a larger than existing customer base. These developments also contribute to the introduction of new trends to the market to a certain extent. A few of the noteworthy developments in the North America transfection reagents and equipment market are mentioned below.

In April 2023, Thermo Fisher Scientific launched the Invitrogen Neon NxT Electroporation System that facilitates transfection, even with the most challenging cell types, enabling high efficiency, cell recovery, and reproducibility. Neon NxT electrodes are optimally placed to provide minimal surface area and create a more uniform electric field, and maintain apt physiological conditions during transfection, thereby enabling the desired modification to take place in more cells and reducing the number of cells lost during the process. The new system also features an improved feedback loop and ergonomic enhancements for ease of use. In August 2021, Mirus Bio launched the TransIT VirusGEN GMP Product Line, which provides transfection reagents and enhancers to support the manufacturing of viral vectors for the development of gene therapies. The TransIT VirusGEN GMP transfection reagent was developed to enhance the delivery of transfer vaccine DNA to suspension and adherent HEK 293 cells to make the production of recombinant AAV and LV vectors more efficient. In July 2020, Polyplus-transfection SA launched the first GMP-compliant residual test for its PEIpro product portfolio of transfection reagents designed to support the development of the preclinical, clinical, and commercial process of lentivirus and adeno-associated virus (AAV) production for cell and gene therapies. In addition, Polyplus-transfection also launched dual sourcing for its PEIpro-GMP product for late-stage and commercialization cell and gene therapies. Thus, the introduction of products such as transfection reagents and systems; the development of innovative products targeting various health issues to create new or improved products; and the initiation of new businesses to remain competitive in the market, all, through collaborations and partnerships can help speed up the development of new platforms for transfection reagents and equipment.

North America Transfection Reagents and Equipment Market Overview

Cell and gene therapies (CGTs) are prescribed to treat patients suffering from serious and rare diseases with unaddressed therapeutic needs. Manufacturing CGTs is a highly complex process, with the insufficiency of infrastructure and expertise being a major limiting factor. Logistics-related challenges associated with intermediates and the final product also limit the CGT manufacturing capacity of companies. The CGT manufacturing process involves the extraction of autologous cells through "apheresis," dispatching them to specialized laboratories and sending them back to clinics for administration into patients, all of which must be performed with strict quality control. The US Food and Drug Administration (FDA) has approved only 7 CGT drugs so far, and the pipeline of new products has reached ~1,200 experimental therapies. Half of these are in Phase 2 clinical trials. With these prospects, annual sales of cell therapies and gene therapies are estimated to grow by 15% and ~30%, respectively, as stated in the Chemical & Engineering News Report 2023.

Many manufacturers approach contract development manufacturing organizations (CDMOs) such as Labcorp, Lonza, and Catalent to overcome the barriers associated with the production and commercialization of their CGT products. Lonza has invested ~US$ 9.2 million to strengthen its cell and gene therapy manufacturing capabilities. Such initiatives by CDMOs are contributing to the growth of the transfection reagents and equipment market in the US.

Furthermore, in February 2022, Francois-Philippe Champagne, the minister of Innovation, Science and Industry, announced the funding of US$ 45 million to the Government of Canada through the Canada Foundation for Innovation (CFI) to ensure that research teams have appropriate labs and infrastructure, and access to technology departments for carrying about world-class research. The Canadian Institutes of Health Research (CIHR) announced a partnership with the Quebec Consortium for Drug Discovery (CQDM) for a new collaborative funding program on personalized medicine to accelerate drug discovery and drug development.

North America Transfection Reagents and Equipment Market Revenue and Forecast to 2030 (US$ Million)

North America Transfection Reagents and Equipment Market Segmentation

The North America transfection reagents and equipment market is segmented based on product, method, application, end user, and country.

Based on product, the North America transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held a larger share in 2022.

In terms of method, the North America transfection reagents and equipment market is segmented into viral methods, non-viral methods, and hybrid methods. The non-viral methods segment held the largest share in 2022. The viral segment is sub categorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is sub categorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is sub categorized into liposomal based/high lipid and non-liposomal/high lipid based.

By application, the North America transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held the largest share in 2022.

Based on end user, the North America transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held a larger share in 2022.

Based on country, the North America transfection reagents and equipment market is categorized into the US, Canada, and Mexico. The US dominated the North America transfection reagents and equipment market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc, and Polyplus-Transfection SA are some of the leading companies operating in the North America transfection reagents and equipment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Transfection Reagents and Equipment Market - Key Market Dynamics

  • 4.1 North America Transfection Reagents and Equipment Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Increasing Popularity of Cell and Gene Therapy
    • 4.2.2 Growing Economic Burden of Cancer
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Instruments and Consumables
  • 4.4 Market Opportunities
    • 4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
  • 4.5 Future Trends
    • 4.5.1 Strategic Initiatives by Companies
  • 4.6 Impact of Drivers and Restraints:

5. Transfection Reagents and Equipment Market - North America Market Analysis

  • 5.1 North America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
  • 5.2 North America Transfection Reagents and Equipment Market Forecast Analysis

6. North America Transfection Reagents and Equipment Market Analysis - by Product

  • 6.1 Reagents
    • 6.1.1 Overview
    • 6.1.2 Reagents: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Equipment
    • 6.2.1 Overview
    • 6.2.2 Equipment: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Transfection Reagents and Equipment Market Analysis - by Modality

  • 7.1 Viral
    • 7.1.1 Overview
    • 7.1.2 Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.1 Retrovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.2 Adenovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.3 Adeno-Associated Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.4 Herpes Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Non-Viral
    • 7.2.1 Overview
    • 7.2.2 Non-Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.1 Physical/Mechanical Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.1 Electroporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.2 Microinjection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.3 Biolistic Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.4 Laser Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.5 Magnetofection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.6 Sonoporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.2 Chemical Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.2.1 Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.2.2 Non-Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Hybrid
    • 7.3.1 Overview
    • 7.3.2 Hybrid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Transfection Reagents and Equipment Market Analysis - by Application

  • 8.1 Biomedical Research
    • 8.1.1 Overview
    • 8.1.2 Biomedical Research: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Protein Production
    • 8.2.1 Overview
    • 8.2.2 Protein Production: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Therapeutic Delivery
    • 8.3.1 Overview
    • 8.3.2 Therapeutic Delivery: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Transfection Reagents and Equipment Market Analysis - by End Users

  • 9.1 Academic and Research Institutes
    • 9.1.1 Overview
    • 9.1.2 Academic and Research Institutes: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Pharmaceutical and Biotechnological Companies
    • 9.2.1 Overview
    • 9.2.2 Pharmaceutical and Biotechnological Companies: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Transfection Reagents and Equipment Market -Country Analysis

  • 10.1 North America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
    • 10.1.1 North America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 United States: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.1.1.2 United States: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.1.1.2.1 United States: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.1.1.2.2 United States: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.1.1.2.2.1 United States: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.1.1.2.2.2 United States: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.1.1.3 United States: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.1.1.4 United States: Transfection Reagents and Equipment Market Breakdown, by End Users
      • 10.1.1.2 Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Canada: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.1.2.2 Canada: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.1.2.2.1 Canada: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.1.2.2.2 Canada: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.1.2.2.2.1 Canada: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.1.2.2.2.2 Canada: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.1.2.3 Canada: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.1.2.4 Canada: Transfection Reagents and Equipment Market Breakdown, by End Users
      • 10.1.1.3 Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Mexico: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.1.3.2 Mexico: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.1.3.2.1 Mexico: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.1.3.2.2 Mexico: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.1.3.2.2.1 Mexico: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.1.3.2.2.2 Mexico: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.1.3.3 Mexico: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.1.3.4 Mexico: Transfection Reagents and Equipment Market Breakdown, by End Users

11. Transfection Reagents and Equipment Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 F. Hoffmann-La Roche Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Bio-Rad Laboratories Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Mirus Bio LLC
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 QIAGEN NV
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Merck KGaA
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Lonza Group AG
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 MaxCyte Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Polyplus-Transfection SA
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us